Yuyu Pharma Inc (000227) - Total Liabilities

Latest as of September 2025: ₩63.32 Billion KRW ≈ $42.91 Million USD

Based on the latest financial reports, Yuyu Pharma Inc (000227) has total liabilities worth ₩63.32 Billion KRW (≈ $42.91 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 000227 shareholders equity momentum to track the company's year-over-year net asset growth rate.

Yuyu Pharma Inc - Total Liabilities Trend (2014–2024)

This chart illustrates how Yuyu Pharma Inc's total liabilities have evolved over time, based on quarterly financial data. See Yuyu Pharma Inc (000227) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Yuyu Pharma Inc Competitors by Total Liabilities

The table below lists competitors of Yuyu Pharma Inc ranked by their total liabilities.

Company	Country	Total Liabilities
Naos Small Cap Opportunities Company Ltd AU:NSC	Australia	AU$13.28 Million
Lantern Pharma Inc NASDAQ:LTRN	USA	$4.04 Million
Western Alaska Minerals Corp V:WAM	Canada	CA$6.35 Million
Greencoat UK Wind PLC LSE:UKW	UK	GBX1.75 Billion
Cannindah Resources Ltd AU:CAE	Australia	AU$109.84K
Karolinska Development AB ser. B ST:KDEV	Sweden	Skr6.55 Million
HOYA Resort Hotel Group TWO:2736	Taiwan	NT$959.85 Million
IT Link PA:ALITL	France	€31.36 Million

Liability Composition Analysis (2014–2024)

This chart breaks down Yuyu Pharma Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Yuyu Pharma Inc (000227) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.77	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.49	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.31	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Yuyu Pharma Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Yuyu Pharma Inc (2014–2024)

The table below shows the annual total liabilities of Yuyu Pharma Inc from 2014 to 2024.

Year	Total Liabilities	Change
2024-12-31	₩72.62 Billion ≈ $49.22 Million	-6.72%
2023-12-31	₩77.86 Billion ≈ $52.76 Million	+8.39%
2022-12-31	₩71.83 Billion ≈ $48.68 Million	+11.71%
2021-12-31	₩64.30 Billion ≈ $43.58 Million	+69.82%
2020-12-31	₩37.86 Billion ≈ $25.66 Million	-19.73%
2019-12-31	₩47.17 Billion ≈ $31.97 Million	-2.44%
2018-12-31	₩48.35 Billion ≈ $32.77 Million	+25.08%
2017-12-31	₩38.66 Billion ≈ $26.20 Million	+17.11%
2016-12-31	₩33.01 Billion ≈ $22.37 Million	+7.88%
2015-12-31	₩30.60 Billion ≈ $20.73 Million	+2.29%
2014-12-31	₩29.91 Billion ≈ $20.27 Million	--

About Yuyu Pharma Inc

KO:000227 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$29.39 Million

₩43.36 Billion KRW

Market Cap Rank

#23778 Global

#1615 in Korea

Share Price

₩7400.00

Change (1 day)

+5.26%

52-Week Range

₩6300.00 - ₩11670.00

All Time High

₩56262.57